Cargando…

Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival

OBJECTIVE: Cholangiocarcinoma (CCA) is a devastating disease. Interferon α-inducible protein 27 (IFI27), originally known to involve in innate immunity, is later found to intervene in cell proliferation, leading to inventive studies regarding the role of IFI27 in cancer treatment. We aimed to invest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Kun-Chun, Huang, Sheng-Teng, Wu, Ren-Chin, Huang, Shih-Chiang, Yeh, Ta-Sen, Chen, Ming-Huang, Hsu, Jun-Te, Chen, Li-Wei, Kuo, Sheng-Fong, Chueh, Ho-Yen, Juang, Horng-Heng, Hung, Shuen-Iu, Yeh, Chun-Nan, Pang, Jong-Hwei S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400119/ https://www.ncbi.nlm.nih.gov/pubmed/30881116 http://dx.doi.org/10.2147/CMAR.S196485

Ejemplares similares

25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2013)

Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma
por: Chiang, Kun-Chun, et al.
Publicado: (2017)

Chemopreventive and chemotherapeutic effects of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model
por: Chiang, Kun-Chun, et al.
Publicado: (2014)

PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo
por: Chiang, Kun-Chun, et al.
Publicado: (2015)

The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

MART-10, a New Generation of Vitamin D Analog, Is More Potent than 1α,25-Dihydroxyvitamin D(3) in Inhibiting Cell Proliferation and Inducing Apoptosis in ER+ MCF-7 Breast Cancer Cells
por: Chiang, Kun-Chun, et al.
Publicado: (2012)

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015)

Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2015)

Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells
por: Yang, Shih-Wei, et al.
Publicado: (2016)

Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2014)

Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors
por: Chen, Jen-Shi, et al.
Publicado: (2018)

WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer
por: Chiang, Kun-Chun, et al.
Publicado: (2015)

Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence
por: Chan, Kun-Ming, et al.
Publicado: (2018)

Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patients
por: Yeh, Chun-Nan, et al.
Publicado: (2017)

Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
por: Tsai, Chun-Yi, et al.
Publicado: (2022)

Non‐small cell lung cancer with gastric metastasis and repeated gastrointestinal bleeding: A rare case report and literature review
por: Shih‐Chun, Chang, et al.
Publicado: (2021)

GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2017)

The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma
por: Huang, Wen-Kuan, et al.
Publicado: (2020)

Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation
por: Pan, Yi-Ru, et al.
Publicado: (2023)

Topoisomerase Inhibitors Modulate Gene Expression of B-Cell Translocation Gene 2 and Prostate Specific Antigen in Prostate Carcinoma Cells
por: Chiang, Kun-Chun, et al.
Publicado: (2014)

Celastrol Blocks Interleukin-6 Gene Expression via Downregulation of NF-κB in Prostate Carcinoma Cells
por: Chiang, Kun-Chun, et al.
Publicado: (2014)

Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma
por: Chang, Yu-Chan, et al.
Publicado: (2020)

Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
por: Chiang, Kun-Chun, et al.
Publicado: (2012)

Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways
por: Chiang, Kun-Chun, et al.
Publicado: (2014)

Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer
por: Hsu, Jun-Te, et al.
Publicado: (2015)

MiRNA-221 negatively regulated downstream p27Kip1 gene expression involvement in pterygium pathogenesis
por: Wu, Chueh-Wei, et al.
Publicado: (2014)

TSGΔ154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation
por: Chua, Huey-Huey, et al.
Publicado: (2016)

A Single-Institute Experience with C-ros Oncogene 1 Translocation in Non-Small Cell Lung Cancers in Taiwan
por: Wang, Hsiang-Sheng, et al.
Publicado: (2022)

Clinicopathological characteristics and outcomes in stage I–III mucinous gastric adenocarcinoma: a retrospective study at a single medical center
por: Hsu, Jun-Te, et al.
Publicado: (2016)

The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes
por: Huang, Shih-Chiang, et al.
Publicado: (2021)

Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma
por: Pan, Yi-Ru, et al.
Publicado: (2022)

N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer: A Modified System Based on Current AJCC Staging
por: Yeh, Chun-Nan, et al.
Publicado: (2015)

Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells
por: Tsui, Ke-Hung, et al.
Publicado: (2019)

Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model
por: Pan, Yi-Ru, et al.
Publicado: (2020)

Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study()
por: Chen, Yen-Yang, et al.
Publicado: (2014)

Oncocytic-type intraductal papillary mucinous neoplasm (IPMN)-derived invasive oncocytic pancreatic carcinoma with brain metastasis - a case report
por: Chiang, Kun-Chun, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_651uo2vnvmd9ms8eb8jnt2qnvc